MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 108 filers reported holding MYOVANT SCIENCES LTD in Q1 2021. The put-call ratio across all filers is 5.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $105,602 | +50.9% | 3,917 | 0.0% | 0.00% | – |
| Q3 2022 | $70,000 | +42.9% | 3,917 | 0.0% | 0.00% | – |
| Q2 2022 | $49,000 | -5.8% | 3,917 | 0.0% | 0.00% | – |
| Q1 2022 | $52,000 | -14.8% | 3,917 | 0.0% | 0.00% | – |
| Q4 2021 | $61,000 | -30.7% | 3,917 | 0.0% | 0.00% | – |
| Q3 2021 | $88,000 | -1.1% | 3,917 | 0.0% | 0.00% | – |
| Q2 2021 | $89,000 | +9.9% | 3,917 | 0.0% | 0.00% | – |
| Q1 2021 | $81,000 | -46.7% | 3,917 | -29.0% | 0.00% | -100.0% |
| Q4 2020 | $152,000 | +94.9% | 5,518 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $78,000 | -31.6% | 5,518 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $114,000 | +171.4% | 5,518 | 0.0% | 0.00% | – |
| Q1 2020 | $42,000 | -51.2% | 5,518 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $86,000 | +616.7% | 5,518 | +133.4% | 0.00% | – |
| Q3 2019 | $12,000 | – | 2,364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
| Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
| VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
| Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
| Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
| Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
| Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
| Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
| Matisse Capital | 32,750 | $508,000 | 0.36% |
| VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |